Please Wait
Applying Filters...

Australian Register of Therapeutic Goods list of Approved Drug Products containing N-(5-(((3,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thenoyl)-L-glutamic acid. Original Data : Therapeutic Goods Administration Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Pfizer Australia Pty Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

raltitrexed

Brand Name : Tomudex

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

raltitrexed

Brand Name : Tomudex

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank